Encore Medical, Inc. (EMI)

Encore Medical Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Encore Medical has 9.74 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	9.74M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.63

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-267.79%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$131,066
Profits Per Employee	-$98,691
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Encore Medical had revenue of $2.10 million and -$1.58 million in losses. Loss per share was -$0.16.

Revenue	2.10M
Gross Profit	918,685
Operating Income	-1.50M
Pretax Income	-1.58M
Net Income	-1.58M
EBITDA	-1.49M
EBIT	-1.50M
Loss Per Share	-$0.16

Balance Sheet

The company has $48,363 in cash and $1.55 million in debt, giving a net cash position of -$1.50 million or -$0.15 per share.

Cash & Cash Equivalents	48,363
Total Debt	1.55M
Net Cash	-1.50M
Net Cash Per Share	-$0.15
Equity (Book Value)	-990,558
Book Value Per Share	-0.10
Working Capital	936,164

Cash Flow

In the last 12 months, operating cash flow was -$554,005 and capital expenditures -$500, giving a free cash flow of -$554,505.

Operating Cash Flow	-554,005
Capital Expenditures	-500
Free Cash Flow	-554,505
FCF Per Share	-$0.06

Margins

Gross margin is 43.81%, with operating and profit margins of -71.46% and -75.30%.

Gross Margin	43.81%
Operating Margin	-71.46%
Pretax Margin	-75.30%
Profit Margin	-75.30%
EBITDA Margin	-71.08%
EBIT Margin	-71.46%
FCF Margin	-26.44%

Dividends & Yields

Encore Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a